02
Feb
2010
Posted in I - Series A, Q - 4Q09, R - INTERNATIONAL, X - Alzheimer's, X - Inflammation
Probiodrug (Germany) a clinical-stage small molecule biopharmaceutical company focused upon Alzheimer’s and inflammation diseases, closed a $54M Series B financing. Participants include BB Biotech, Edmond de Rothschild Investment Partners, Life Science Partners, Biogen Idec New Ventures, HBM Bioventures and TVM Capital.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb
31
Jan
2010
Posted in I - Series B, Q - 4Q09, R - INTERNATIONAL, X - Device (Diagnostic)
Kreatech Diagnostics (Netherlands) a commercial-stage molecular diagnostics company focused on DNA FISH probes and nucleic acid labeling technologies, closed a $2.7M Series B financing. Participants include Alafi Capital and Life Science Partners.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb